Premium
Over‐expression of cyclin a is highly associated with early relapse and reduced survival in patients with primary breast carcinomas
Author(s) -
Bukholm Ida R.K.,
Bukholm Geir,
Nesland Jahn M.
Publication year - 2001
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.1311
Subject(s) - cyclin , cyclin d1 , cyclin d3 , breast cancer , cyclin dependent kinase , cancer research , cyclin e , cell cycle , cyclin a , immunohistochemistry , cyclin b , biology , cyclin d , oncology , carcinogenesis , univariate analysis , survival analysis , proportional hazards model , cancer , medicine , multivariate analysis
Progression through the mammalian cell cycle is facilitated by cyclin–cyclin‐dependent kinase (cdk) complexes, which are activated at specific points during the cell cycle. Alteration in cyclin–cdk complexess may lead to altered cell cycle and tumorigenesis. In this study, we analyzed expression of cyclins A, D1, D3 and E in tumor tissue from 170 patients with primary invasive breast carcinomas. Immunohistochemical methods were used to detect protein expression of these cyclins. We detected positive immunoreactivity in 55 (32%), 22 (13%), 38 (22%) and 37 (21.8%) of the samples for cyclins A, D1, D3 and E, respectively. A highly statistically significant association was observed between expression of cyclin A and early relapse ( p = 0.001 univariate analysis, p = 0.006 multivariate analysis) as well as cancer‐specific death ( p < 0.0001) during the follow‐up time. No association was observed between cyclin D1 or cyclin E, respectively, and relapse of disease or survival, while cyclin D3 over‐expression was associated with development of metastases during follow‐up ( p = 0.005 univariate analysis, p = 0.01 multivariate analysis). However, cyclin D3 did not show any statistically significant association when cancer‐specific death was examined in a multivariate analysis (Cox regression for survival function). © 2001 Wiley‐Liss, Inc.